Cutibacterium acnes IA1
Selected indexed studies
- The Skin Microbiome: A New Actor in Inflammatory Acne. (Am J Clin Dermatol, 2020) [PMID:32910436]
- Cutibacterium acnes molecular typing: time to standardize the method. (Clin Microbiol Infect, 2018) [PMID:29544912]
- Transcriptomic and metabolomic analyses of the antimicrobial activity of phenoxyethanol against phylotype IA1 and II Cutibacterium acnes. (J Appl Microbiol, 2025) [PMID:40261688]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cutibacterium acnes molecular typing: time to standardize the method. (2018) pubmed
- Different Cutibacterium acnes Phylotypes Release Distinct Extracellular Vesicles. (2022) pubmed
- The Skin Microbiome: A New Actor in Inflammatory Acne. (2020) pubmed
- Transcriptomic and metabolomic analyses of the antimicrobial activity of phenoxyethanol against phylotype IA1 and II Cutibacterium acnes. (2025) pubmed
- Biofilm of Cutibacterium acnes: a target of different active substances. (2024) pubmed
- Characterisation of the Novel Cutibacterium acnes Phage KIT09 and First Report of CRISPR-Cas-Independent Bacteriophage Resistance in Phylotype IA1. (2025) pubmed
- Genomics of Invasive Cutibacterium acnes Isolates from Deep-Seated Infections. (2023) pubmed
- Acne fulminans and Cutibacterium acnes phylotypes. (2020) pubmed
- Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. (2022) pubmed
- Pro-inflammatory activity of Cutibacterium acnes phylotype IA(1) and extracellular vesicles: An in vitro study. (2024) pubmed